Discovery of Novel FtsZ Inhibitors With Antimicrobial Activity by Virtual Screening and In Vitro Biological Evaluation
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202403042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Aoqi Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Marine Bioresources and Environment, Jiangsu Key Laboratory of Marine Biotechnology, School of Pharmacy, Jiangsu Ocean Univ…. Hauptthemen laut MEDLINE: Cytoskeletal Proteins, Bacterial Proteins, Anti-Bacterial Agents, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).
Abstract (Originalsprache)
The filamentous temperature‐sensitive protein Z (FtsZ) plays a vital role in bacterial division, making it an important antibacterial target. The inhibitor activity targeting the cleft between the H7 helix and the C‐terminal substructural domain exhibited superior binding compared to the GTP binding site. This highlights the potential of the cleft as a promising target for further inhibitor discovery. In this study, we established a virtual screening (VS) pipeline using Discovery Studio software and employed FRED for molecular docking and Functional‐Class Fingerprints_6 (FCFP_6) for molecular clustering, resulting in the identification of 38 potentially active compounds. These 38 compounds were then subjected to the following FtsZ inhibition assays, resulting in the four active compounds B6, B21, B26, and B31. Further experiments showed that compounds B6 and B26 exhibited antimicrobial activity with minimum inhibitory concentration (MIC) values of 8 and 32 µg/mL. Finally, molecular dynamics (MD) was used to analyze the binding modes of the protein‐ligand. In addition, we predicted the physicochemical properties and toxicity of B6 and B26. In summary, our study successfully identified novel FtsZ inhibitors with antimicrobial activity through VS and in vitro biological evaluation, demonstrating their potential for further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Marine Bioresources and Environment, Jiangsu Key Laboratory of Marine Biotechnology, School of Pharmacy, Jiangsu Ocean University, Lianyungang, Jiangsu, China.
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
ORCID-Profile: Xinxin Si
Förderung
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
Zitieren
APA
Luo, A., Qian, C., Zhang, Z., Xia, J., Jin, H., Si, X., & Ma, S. (2025). Discovery of Novel FtsZ Inhibitors With Antimicrobial Activity by Virtual Screening and In Vitro Biological Evaluation. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202403042
Vancouver
Luo A, Qian C, Zhang Z, Xia J, Jin H, Si X, et al. Discovery of Novel FtsZ Inhibitors With Antimicrobial Activity by Virtual Screening and In Vitro Biological Evaluation. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202403042
BibTeX
@article{Luo2025,
author = {Luo, Aoqi and Qian, Chenliang and Zhang, Zhenyu and Xia, Jie and Jin, Hongwei and Si, Xinxin and Ma, Shaojie},
title = {Discovery of Novel FtsZ Inhibitors With Antimicrobial Activity by Virtual Screening and In Vitro Biological Evaluation},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202403042}
}
EUVIMED